Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Biotech Stars And Startups Raise $168m In Venture Cash

This article was originally published in Scrip

Executive Summary

Drug developers continue to raise significant venture capital in 2015 with experienced executives and novel therapeutic approaches attracting large VC funding rounds to support early-stage research and development programs, including a $40m Series C round for True North Therapeutics.

Advertisement

Related Content

VC Roundup: October Brings Several New Venture Funds, Including Third Rock’s Fourth

Topics

Advertisement
UsernamePublicRestriction

Register